2-((3,4-DIHYDROISOQUINOLIN)-3-SPIROCYCLOHEXAN-1-YLAMINO)ACETIC ACID
- $378 - $768.08
- Product name: 2-((3,4-DIHYDROISOQUINOLIN)-3-SPIROCYCLOHEXAN-1-YLAMINO)ACETIC ACID
- CAS: 500006-77-9
- MF: C16H20N2O2
- MW: 272.34
- EINECS:
- MDL Number:MFCD03017310
- Synonyms:SPIRO[CYCLOHEXANE-1,3'-(3',4'-DIHYDRO-ISOQUINOLIN)]-1'-YL-AMINOACETIC ACID;TIMTEC-BB SBB001076;2-((3,4-DIHYDROISOQUINOLIN)-3-SPIROCYCLOHEXAN-1-YLAMINO)ACETIC ACID;Glycine, N-spiro[cyclohexane-1,3'(4'H)-isoquinolin]-1'-yl-;Spiro[cyclohexane-1,3'-(3',4'-dihydro-isoquinolin)]-1'-yl-aminoacetic acid
3 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500MG
- 1g
- ManufacturerAK Scientific
- Product number4326AE
- Product descriptionSpiro[cyclohexane-1,3'-(3',4'-dihydro-isoquinolin)]-1'-yl-aminoaceticacid
- Packaging1g
- Price$560
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0140425
- Product descriptionSPIRO[CYCLOHEXANE-1,3'-(3',4'-DIHYDRO-ISOQUINOLIN)]-1'-YL-AMINOACETIC ACID 95.00%
- Packaging500MG
- Price$768.08
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010834
- Product descriptionSpiro[cyclohexane-1,3'-(3',4'-dihydro-isoquinolin)]-1'-yl-aminoacetic acid
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 4326AE | Spiro[cyclohexane-1,3'-(3',4'-dihydro-isoquinolin)]-1'-yl-aminoaceticacid | 1g | $560 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0140425 | SPIRO[CYCLOHEXANE-1,3'-(3',4'-DIHYDRO-ISOQUINOLIN)]-1'-YL-AMINOACETIC ACID 95.00% | 500MG | $768.08 | 2021-12-16 | Buy |
Matrix Scientific | 010834 | Spiro[cyclohexane-1,3'-(3',4'-dihydro-isoquinolin)]-1'-yl-aminoacetic acid | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|